NVIDIA’s invention of the GPU sparked the PC gaming market. The company’s pioneering work in accelerated computing—a supercharged form of computing at the intersection of computer graphics, high performance computing, and AI—is reshaping trillion-dollar industries such as healthcare and pharmaceuticals, and fueling the growth of many others. NVIDIA ClaraTM, a GPU-accelerated application framework for medical imaging, genomics, smart hospitals, medical instruments, and basic life science research, is helping to accelerate breakthrough discoveries across the industry, often bringing disparate pieces of information together faster than previously done and with ever larger data sets. NVIDIA Clara Parabricks is an accelerated genomic analysis software suite that supports end-to-end analysis pipelines for next-generation sequencing applications. With over 30 accelerated tools, including 2 germline callers (GATK’s Haplotype caller and Google’s DeepVariant), three structural variant callers (Manta, Smoove, and CNVkit), and 5 somatic callers (MuSE, LoFreq, SomaticSniper, Mutect2, and Strelka), researchers can identify more genetic variants within their data in minutes to hours when compared to traditional CPU platforms. Starting with an accelerated BWA-MEM, Clara Parabricks supports the best practices pipelines established by Broad’s GATK, generating identical results in a fraction of the time. Clara Parabricks supports germline, somatic, and RNA based applications, and offers a free 90 day evaluation to get started.